These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 2480498

  • 1. Endothelial cell activation and high interleukin-1 secretion in the pathogenesis of acute Kawasaki disease.
    Leung DY, Cotran RS, Kurt-Jones E, Burns JC, Newburger JW, Pober JS.
    Lancet; 1989 Dec 02; 2(8675):1298-302. PubMed ID: 2480498
    [Abstract] [Full Text] [Related]

  • 2. The potential role of cytokine-mediated vascular endothelial activation in the pathogenesis of Kawasaki disease.
    Leung DY.
    Acta Paediatr Jpn; 1991 Dec 02; 33(6):739-44. PubMed ID: 1801553
    [Abstract] [Full Text] [Related]

  • 3. Endothelial activation during interleukin 2 immunotherapy. A possible mechanism for the vascular leak syndrome.
    Cotran RS, Pober JS, Gimbrone MA, Springer TA, Wiebke EA, Gaspari AA, Rosenberg SA, Lotze MT.
    J Immunol; 1988 Mar 15; 140(6):1883-8. PubMed ID: 3279124
    [Abstract] [Full Text] [Related]

  • 4. Endothelial leucocyte adhesion molecule-1 (ELAM-1) expression in cutaneous inflammation.
    Groves RW, Allen MH, Barker JN, Haskard DO, MacDonald DM.
    Br J Dermatol; 1991 Feb 15; 124(2):117-23. PubMed ID: 1706195
    [Abstract] [Full Text] [Related]

  • 5. Cytokine production (IL-1 alpha, IL-1 beta, and TNF alpha) and endothelial cell activation (ELAM-1 and HLA-DR) in reactive lymphadenitis, Hodgkin's disease, and in non-Hodgkin's lymphomas. An immunocytochemical study.
    Ruco LP, Pomponi D, Pigott R, Stoppacciaro A, Monardo F, Uccini S, Boraschi D, Tagliabue A, Santoni A, Dejana E.
    Am J Pathol; 1990 Nov 15; 137(5):1163-71. PubMed ID: 1700619
    [Abstract] [Full Text] [Related]

  • 6. Endothelial activation in the pathogenesis of Kawasaki disease.
    Leung DY, Cotran RS, Kurt-Jones E, Burns JC, Newburger JW, Pober JS.
    Trans Assoc Am Physicians; 1989 Nov 15; 102():131-8. PubMed ID: 2484114
    [No Abstract] [Full Text] [Related]

  • 7. New developments in Kawasaki disease.
    Leung DY.
    Curr Opin Rheumatol; 1991 Feb 15; 3(1):46-55. PubMed ID: 1710476
    [Abstract] [Full Text] [Related]

  • 8. Involvement of cytokines and vascular adhesion receptors in the pathology of fronto-ethmoidal mucocoeles.
    Lund VJ, Henderson B, Song Y.
    Acta Otolaryngol; 1993 Jul 15; 113(4):540-6. PubMed ID: 7691023
    [Abstract] [Full Text] [Related]

  • 9. Clinical and immunologic aspects of Kawasaki disease.
    Leung DY.
    Immunodefic Rev; 1989 Jul 15; 1(3):261-71. PubMed ID: 2698643
    [Abstract] [Full Text] [Related]

  • 10. Two monokines, interleukin 1 and tumor necrosis factor, render cultured vascular endothelial cells susceptible to lysis by antibodies circulating during Kawasaki syndrome.
    Leung DY, Geha RS, Newburger JW, Burns JC, Fiers W, Lapierre LA, Pober JS.
    J Exp Med; 1986 Dec 01; 164(6):1958-72. PubMed ID: 3491174
    [Abstract] [Full Text] [Related]

  • 11. Immunological abnormalities and endothelial cell injury in Kawasaki disease.
    Nonoyama S.
    Acta Paediatr Jpn; 1991 Dec 01; 33(6):752-5. PubMed ID: 1801555
    [Abstract] [Full Text] [Related]

  • 12. Expression of immunologically relevant endothelial cell activation antigens on isolated central nervous system microvessels from patients with multiple sclerosis.
    Washington R, Burton J, Todd RF, Newman W, Dragovic L, Dore-Duffy P.
    Ann Neurol; 1994 Jan 01; 35(1):89-97. PubMed ID: 7506877
    [Abstract] [Full Text] [Related]

  • 13. Heterogeneity of dermal microvascular endothelial cell antigen expression and cytokine responsiveness in situ and in cell culture.
    Petzelbauer P, Bender JR, Wilson J, Pober JS.
    J Immunol; 1993 Nov 01; 151(9):5062-72. PubMed ID: 7691964
    [Abstract] [Full Text] [Related]

  • 14. Immunomodulation by intravenous immune globulin in Kawasaki disease.
    Leung DY.
    J Allergy Clin Immunol; 1989 Oct 01; 84(4 Pt 2):588-93; discussion 593-4. PubMed ID: 2677095
    [Abstract] [Full Text] [Related]

  • 15. Inflammatory parameters and soluble cell adhesion molecules in Swedish children with Kawasaki disease: relationship to cardiac lesions and intravenous immunoglobulin treatment.
    Schiller B, Elinder G.
    Acta Paediatr; 1999 Aug 01; 88(8):844-8. PubMed ID: 10503683
    [Abstract] [Full Text] [Related]

  • 16. Cytokine modulation with immune gamma-globulin in peripheral blood of normal children and its implications in Kawasaki disease treatment.
    Gupta M, Noel GJ, Schaefer M, Friedman D, Bussel J, Johann-Liang R.
    J Clin Immunol; 2001 May 01; 21(3):193-9. PubMed ID: 11403226
    [Abstract] [Full Text] [Related]

  • 17. Elevated expression in situ of selectin and immunoglobulin superfamily type adhesion molecules in retroocular connective tissues from patients with Graves' ophthalmopathy.
    Heufelder AE, Bahn RS.
    Clin Exp Immunol; 1993 Mar 01; 91(3):381-9. PubMed ID: 7680294
    [Abstract] [Full Text] [Related]

  • 18. IL-4 regulates endothelial cell activation by IL-1, tumor necrosis factor, or IFN-gamma.
    Thornhill MH, Haskard DO.
    J Immunol; 1990 Aug 01; 145(3):865-72. PubMed ID: 1695647
    [Abstract] [Full Text] [Related]

  • 19. Characterization of the adherence of human monocytes to cytokine-stimulated human macrovascular endothelial cells.
    Beekhuizen H, Corsèl-Van Tilburg AJ, Blokland I, Van Furth R.
    Immunology; 1991 Dec 01; 74(4):661-9. PubMed ID: 1723715
    [Abstract] [Full Text] [Related]

  • 20. Up-regulation of intercellular adhesion molecule-1 (ICAM-1), endothelial leucocyte adhesion molecule-1 (ELAM-1) and class II MHC molecules on pulmonary artery endothelial cells by antibodies against U1-ribonucleoprotein.
    Okawa-Takatsuji M, Aotsuka S, Fujinami M, Uwatoko S, Kinoshita M, Sumiya M.
    Clin Exp Immunol; 1999 Apr 01; 116(1):174-80. PubMed ID: 10209523
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.